Downing Distribution VCT 1 plc
Interim Management Statement
for the three months ended 30 June 2011
In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK
Listing Authority Downing Distribution VCT 1 plc presents an Interim Management
Statement for the three month period ended 30 June 2011. Â The statement also
includes relevant financial information between the end of the period and the
date of this statement.
Performance
 31 Jul 30 Jun 31 Mar
2011 2011 2011
(Unaudited) (Unaudited) (Audited)
 Pence Pence Pence
Net Asset Value 87.5 90.0 92.0
Cumulative distributions paid since 1 April 5.0 5.0 5.0
2010
Total return 92.5 95.0 97.0
Dividends paid or declared in the period
On 28 July 2011 the Company declared a final dividend of 2.5p per share for the
year to 31 March 2011, payable on 30 September 2011, subject to Shareholder
approval.
Investment portfolio summary at 30 June 2011
Valuation
movement
since
 31 March
  Cost Valuation  2011 *
  £'000 £'000
Ten largest investments by value
Cadbury House Holdings Limited Unquoted 2,518 2,546 -
Hoole Hall Country Club Holdings Limited Unquoted 2,100 2,100 -
Ludorum plc  2,161 1,946 (267)
Hoole Hall Spa and Leisure Limited Unquoted 1,020 1,020 -
Animalcare Group plc  637 902 80
First Care Limited Unquoted 879 879 -
IDOX plc  372 768 194
Plastics Capital plc  182 574 32
Craneware plc  371 565 56
Tristel plc  631 534 (104)
Subtotal  10,871 11,834 (9)
Other venture capital investments  10,310 5,947 (303)
Listed fixed income securities  558 346 (10)
Total  21,739 18,127 (322)
All investments are quoted on AIM unless otherwise stated.
*After accounting for additions and disposals in the period.
Investment additions during the three month period ended 30 June 2011
  Cost
  £'000
Future Biogas (SF) Limited Unquoted 14
Sinclair IS Pharma plc ** Â 611
Tracsis plc  100
--------
  725
Since the period end, the Company invested a further £20,000 in Financial News
Publishing Limited.
Investment disposals during the three month period ended 30 June 2011
  Market   Total
 value at  Gain/(loss) realised
  1 April Disposal against cost gain/(loss) in
Cost 2011 * Â proceeds period
 £'000 £'000 £'000 £'000 £'000
@UK plc 6 80 75 69 (5)
Animalcare Group plc 120 155 162 42 7
Aortech International
plc 569 39 29 (540) (10)
Atlantic Global plc 50 28 26 (24) (2)
Deltex Medical Group
plc 75 80 74 (1) (6)
IS Pharma plc ** 392 588 611 219 23
Plastics Capital plc 42 124 117 75 (7)
Sinclair IS Pharma plc 286 286 257 (29) (29)
The Kellan Group plc 34 24 24 (10) -
Zamano plc 32 8 6 (26) (2)
----------------------------------------------------------
 1,606 1,412 1,381 (225) (31)
*After accounting for purchases in the period
** IS Pharma plc was taken over by Sinclair IS Pharma plc in the period under a
"share for share" exchange.
The Company sold holdings in @UK plc, IDOX plc and Media Square plc after the
period end, receiving total proceeds of £86,712.
Changes to share capital
 Shares £'000
As at 1 April 2011 20,823,586 208
Shares issued in period - -
Shares bought back and cancelled - -
---------------------
As at 30 June 2011 20,823,586 208
On 28 July 2011, the Company purchased 280,000 shares for cancellation.
Material events
Other than described above, there were no material events during the period from
1 April 2011 to 30 June 2011 or in the period from 1 July 2011 to the date of
this announcement.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Downing Distribution VCT 1 plc via Thomson Reuters ONE
[HUG#1536265]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.